TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Diabetes mellitus remains one of the most pressing problems in the 21st century. The research objective was to study the level of glycotoxins and oxidation-reduction potential of a serum/cell at the complicated and uncomplicated course of diabetes mellitus type 2 was and find the ways to correct the...

Full description

Bibliographic Details
Main Authors: N. A. Shemyakina, E. V. Namokonov, M. A. Darenskaya
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2017-11-01
Series:Acta Biomedica Scientifica
Subjects:
Online Access:https://www.actabiomedica.ru/jour/article/view/491
_version_ 1797237349586829312
author N. A. Shemyakina
E. V. Namokonov
M. A. Darenskaya
author_facet N. A. Shemyakina
E. V. Namokonov
M. A. Darenskaya
author_sort N. A. Shemyakina
collection DOAJ
description Diabetes mellitus remains one of the most pressing problems in the 21st century. The research objective was to study the level of glycotoxins and oxidation-reduction potential of a serum/cell at the complicated and uncomplicated course of diabetes mellitus type 2 was and find the ways to correct the disorder. Materials and methods. There were three groups of patients aged from 55 up to 70 years, a total of 80 people. The main group (group No. 3) was presented by 40 men suffering from a diabetes mellitus type 2 with a macrovascular disease of the lower extremities. Depending on the chosen remedy and the carried-out therapy, patients of the first group were sectioned into subgroups on 20 people, in the 2nd subgroup additionally N-acetylcysteine solution was introduced in a daily dose of 600 mg once, intravenously, within 7 days. Definition of the studied indicators was made by HPLS methods, prior to therapy, for the third and seventh day. Results. Obtained data confirm activation of polyol pathway of glucose disintegration. Antioxidant potential of the serum and cells decreases. Using N-acetylcysteini in complex therapy reduces implications of carbonyl and oxidative stresses, due to multiple decrease of the final products of glycation. Conclusions. When identifying the presented indicators in patients with diabetic macroangiopathy of the lower extremities, the administration of N-acetylcysteine, intravenously in a daily dose of 600 mg (7 days course) is recommended.
first_indexed 2024-03-08T12:18:09Z
format Article
id doaj.art-975c2325529a48d7b18ada06a3f5f2e0
institution Directory Open Access Journal
issn 2541-9420
2587-9596
language Russian
last_indexed 2024-04-24T17:18:20Z
publishDate 2017-11-01
publisher Scientific Сentre for Family Health and Human Reproduction Problems
record_format Article
series Acta Biomedica Scientifica
spelling doaj.art-975c2325529a48d7b18ada06a3f5f2e02024-03-28T07:49:19ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962017-11-012616717110.12737/article_5a0a8ee3048e76.65175111491TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUSN. A. Shemyakina0E. V. Namokonov1M. A. Darenskaya2ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава РоссииФГБОУ ВО «Читинская государственная медицинская академия» Минздрава РоссииФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»Diabetes mellitus remains one of the most pressing problems in the 21st century. The research objective was to study the level of glycotoxins and oxidation-reduction potential of a serum/cell at the complicated and uncomplicated course of diabetes mellitus type 2 was and find the ways to correct the disorder. Materials and methods. There were three groups of patients aged from 55 up to 70 years, a total of 80 people. The main group (group No. 3) was presented by 40 men suffering from a diabetes mellitus type 2 with a macrovascular disease of the lower extremities. Depending on the chosen remedy and the carried-out therapy, patients of the first group were sectioned into subgroups on 20 people, in the 2nd subgroup additionally N-acetylcysteine solution was introduced in a daily dose of 600 mg once, intravenously, within 7 days. Definition of the studied indicators was made by HPLS methods, prior to therapy, for the third and seventh day. Results. Obtained data confirm activation of polyol pathway of glucose disintegration. Antioxidant potential of the serum and cells decreases. Using N-acetylcysteini in complex therapy reduces implications of carbonyl and oxidative stresses, due to multiple decrease of the final products of glycation. Conclusions. When identifying the presented indicators in patients with diabetic macroangiopathy of the lower extremities, the administration of N-acetylcysteine, intravenously in a daily dose of 600 mg (7 days course) is recommended.https://www.actabiomedica.ru/jour/article/view/491glyoxalmethylglyoxalmalondialdehydediabetescomplications of diabetescysteineglutathioneantioxidant system
spellingShingle N. A. Shemyakina
E. V. Namokonov
M. A. Darenskaya
TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Acta Biomedica Scientifica
glyoxal
methylglyoxal
malondialdehyde
diabetes
complications of diabetes
cysteine
glutathione
antioxidant system
title TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_full TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_fullStr TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_full_unstemmed TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_short TO THE QUESTION OF DIAGNOSTICS AND WAYS OF CORRECTION OF THE DIABETIC MACROVASCULAR DISEASE OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
title_sort to the question of diagnostics and ways of correction of the diabetic macrovascular disease of the lower extremities in patients with type 2 diabetes mellitus
topic glyoxal
methylglyoxal
malondialdehyde
diabetes
complications of diabetes
cysteine
glutathione
antioxidant system
url https://www.actabiomedica.ru/jour/article/view/491
work_keys_str_mv AT nashemyakina tothequestionofdiagnosticsandwaysofcorrectionofthediabeticmacrovasculardiseaseofthelowerextremitiesinpatientswithtype2diabetesmellitus
AT evnamokonov tothequestionofdiagnosticsandwaysofcorrectionofthediabeticmacrovasculardiseaseofthelowerextremitiesinpatientswithtype2diabetesmellitus
AT madarenskaya tothequestionofdiagnosticsandwaysofcorrectionofthediabeticmacrovasculardiseaseofthelowerextremitiesinpatientswithtype2diabetesmellitus